Evidence into Practice: evaluating a Child-centred intervention for diabetes medicine management

Conditions

Type one diabetes Nutritional, Metabolic, Endocrine Insulin-dependent diabetes mellitus

Jane Noyes, Davina Allen, Cynthia Carter, Deborah Edwards, Rhiannon Tudor Edwards et al. (12 authors)

BMJ Open2020-03-018 citations

10.1136/bmjopen-2019-032163

Developing and evaluating a child-centred intervention for diabetes medicine management using mixed methods and a multicentre randomised controlled trial

Jane P Noyes, Lesley Lowes, Rhiannon Whitaker, Davina Allen, Cynthia Carter et al. (13 authors)

Health Services and Delivery Research2014-03-0110 citations

10.3310/hsdr02080

Introduction to a generalized method for adaptive randomization in trials.

Hoare ZS, Whitaker CJ, Whitaker R.

2013-01-175 citations

10.1186/1745-6215-14-19

Evidence into practice: evaluating a child-centred intervention for diabetes medicine management. The EPIC Project.

Noyes JP, Williams A, Allen D, Brocklehurst P, Carter C, Gregory JW, Jackson C, Lewis M, Lowes L, Russell IT, Rycroft-Malone J, Sharp J, Samuels M, Edwards RT, Whitaker R.

2010-09-279 citations

10.1186/1471-2431-10-70

Interventions

The investigation is a mixed-method study informed by the 'Promoting Action on Research Implementation in Health Services' (PARIHS) framework which has been widely used to inform design and evaluation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Children aged 6 - 18 years, either sex 2. Type one diabetes

Exclusion criteria

Exclusion criteria: 1. Severe learning difficulties 2. Significant social problems 3. Needle phobias

Design outcomes

Primary

Measure	Time frame
Choice of outcomes is guided by Health Technology Assessment (HTA) commissioned systematic reviews recommending that HbA1c (glycaemic control measure) is not the appropriate primary outcome on which to assess benefits of an intervention designed to more directly effect behaviour/self-management. Therefore, the primary outcome measure is diabetes self-efficacy and quality-of-life using the Diabetes Pediatric Quality of Life Inventory (PedsQol). Outcomes will be measured at baseline, 3 months (follow-up 1) and 6 months (follow-up 2).	—

Measure

Time frame

Choice of outcomes is guided by Health Technology Assessment (HTA) commissioned systematic reviews recommending that HbA1c (glycaemic control measure) is not the appropriate primary outcome on which to assess benefits of an intervention designed to more directly effect behaviour/self-management. Therefore, the primary outcome measure is diabetes self-efficacy and quality-of-life using the Diabetes Pediatric Quality of Life Inventory (PedsQol). Outcomes will be measured at baseline, 3 months (follow-up 1) and 6 months (follow-up 2).

—

Secondary

Measure	Time frame
1. HbA1c 2. Generic quality of life 3. Routinely collected NHS/child-held data costs 4. Service use 5. Acceptability/utility Outcomes will be measured at baseline, 3 months (follow-up 1) and 6 months (follow-up 2).	—

Countries

United Kingdom

Outcome results

None listed